Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care
- PMID: 37035223
- PMCID: PMC10075036
- DOI: 10.4239/wjd.v14.i3.198
Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has heavily affected health worldwide, with the various forms of diabetes in children experiencing changes at various levels, including epidemiology, diabetic ketoacidosis rates and medical care. Type 1 diabetes showed an apparent increase in incidence, possibly owing to a direct damage of the virus to the β-cell. Diabetic ketoacidosis also increased in association with the general fear of referring patients to the hospital. Most children with diabetes (both type 1 and type 2) did not show a worsening in metabolic control during the first lockdown, possibly owing to a more controlled diet by their parents. Glucose sensor and hybrid closed loop pump technology proved to be effective in all patients with type 1 diabetes during the pandemic, especially because the downloading of data allowed for the practice of tele-medicine. Telemedicine has in fact grown around the world and National Health Systems have started to consider it as a routine activity in clinical practice. The present review encompasses all the aspects related to the effects of the pandemic on the different forms of diabetes in children.
Keywords: COVID-19; Children; Diabetes; Diabetic ketoacidosis; Telemedicine.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare no conflicts of interest.
Similar articles
-
The impact of COVID-19 pandemic on the incidence, presentation, and management of type 1 diabetes in children and adolescents: a narrative review.Hormones (Athens). 2025 Apr 18. doi: 10.1007/s42000-025-00662-2. Online ahead of print. Hormones (Athens). 2025. PMID: 40249463 Review.
-
Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries.Lancet Diabetes Endocrinol. 2022 Nov;10(11):786-794. doi: 10.1016/S2213-8587(22)00246-7. Epub 2022 Oct 3. Lancet Diabetes Endocrinol. 2022. PMID: 36202118 Free PMC article.
-
Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study.Pediatr Endocrinol Diabetes Metab. 2020;26(4):167-175. doi: 10.5114/pedm.2020.101003. Pediatr Endocrinol Diabetes Metab. 2020. PMID: 33554490 English.
-
How the COVID-19 Pandemic Impacted Medical Education during the Last Year of Medical School: A Class Survey.Life (Basel). 2021 Mar 30;11(4):294. doi: 10.3390/life11040294. Life (Basel). 2021. PMID: 33808274 Free PMC article.
-
COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic.Expert Rev Endocrinol Metab. 2023 Mar;18(2):167-179. doi: 10.1080/17446651.2023.2176300. Epub 2023 Feb 16. Expert Rev Endocrinol Metab. 2023. PMID: 36797835 Review.
Cited by
-
Endocrinological Involvement in Children and Adolescents Affected by COVID-19: A Narrative Review.J Clin Med. 2023 Aug 11;12(16):5248. doi: 10.3390/jcm12165248. J Clin Med. 2023. PMID: 37629291 Free PMC article. Review.
References
-
- World Health Organization. WHO Coronavirus (COVID-19) Dashboard. [cited 10 January 2023]. Available from: https://covid19.who.int/
-
- Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW the Northwell COVID-19 Research Consortium, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052–2059. - PMC - PubMed
-
- Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–943. - PMC - PubMed
-
- Kapoor N, Kalra S, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO) The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact. Diabetes Ther. 2022;13:1723–1736. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources